What does a hybrid team working at the interface of machine learning and biomedicine look like? In this episode, I chat with Daphne Koller, Founder and CEO of insitro, about a data-first approach to drug discovery, building the systems that enable large-scale learning, and the importance of a bilingual culture in "digital biology".

Check out the glossary of terms, definitions, and resources (and get a sneak peak of the future conversations lined up!) here: bit.ly/datapulse-glossary